Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      George Kypriotakis Image

      George Kypriotakis, PhD

      Department of Behavioral Science, Division of Cancer Prevention and Population Sciences

      About Dr. George Kypriotakis

      Dr. George Kypriotakis is a Sociologist and Quantitative Methodologist with interests in psychosocial processes related to cancer preventive behaviors.  His work is interdisciplinary – cutting across statistics, sociology, psychology and health.  Kypriotakis’ current scholarship focuses on methodological issues in the design and analysis of experimental and observational studies related to risky behaviors (such as tobacco use) and on the etiology of the social context to generate such behaviors.  In this work, he situates propensity of tobacco use, treatment effectiveness and abstinence within the individuals’ psychosocial processes, with special attention to social determinants.

      In addition to this stream of research, Dr. Kypriotakis is branching into new areas of collaboration. For example, he is involved in a research team bringing together tobacco pharmacotherapy and genetics to identify interactions that shape smoking cessation and nicotine dependence. He is also collaborating with brain imaging researchers to improve classification of individuals into neuroaffective typologies using Bayesian methods.


      Read More

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Behavioral Science, Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Associate Professor, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2012Case Western Reserve, Cleveland, Ohio, US, Sociology, Ph.D
      2001University of Massachusetts, Boston, Massachusetts, US, Applied Sociology, MA
      1997Hellenic College, Boston, Massachusetts, US, Human Development, BA

      Postgraduate Training

      2013-2015Research Fellowship, Tobacco Clinical Trials & Observational Studies, UT MD Anderson Cancer Center, Houston, Texas

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023

      Instructor, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2017

      Other Professional Positions

      Postdoctoral Fellow, UT MD Anderson Cancer Center, Houston, TX, 2013 - 2015

      Director, GRECC Methodology Center, Louis Stokes VA Medical Center, Cleveland, OH, 2010 - 2012

      Biostatistician, Case Western Reserve University, Cleveland, OH, 2008 - 2013

      Education Evaluator, Louis Stokes VA Medical Center, Cleveland, OH, 2008 - 2010

      Research Analyst, Metro Health Medical Center, Cleveland, OH, 2004 - 2007

      Psychosocial Researcher/Evaluator , Sergeant (SGT), Hellenic Army, 2002 - 2004

      Quality Assurance Analyst, Frictionless Commerce (MIT Startup), Cambridge, MA, 1999 - 2002

      Intramural Institutional Committee Activities

      Member, Behavioral Science Junior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Member, Instituational Research Grant (IRG) Program, Ad Hoc Reviewer, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Extramural Institutional Committee Activities

      Member, Data Biospecimen Access Committee (DBAC), The University of Texas MD Anderson Cancer Center, 2022 - 2024

      Member, Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present

      Member, Scientific Review Committee (SRC 4), The University of Texas MD Anderson Cancer Center, 2017 - Present

      Editorial Activities

      Guest Editor, Inequalities and Tobacco Use, 2022

      Advisory Member Board, Methods X, 2019 - Present

      Professional Memberships

      The Southern Sociological Society (SSS)

      2021 - Present

      Population Association of America

      2020 - 2022

      Society of Behavioral Medicine

      2013 - Present

      Society for Research on Nicotine and Tobacco

      2013 - Present

      International Society for Bayesian Analysis

      2008 - Present

      International Society of Quality of Life Studies

      2007 - 2010

      American Sociological Association

      2005 - Present

      Society for the Study of Social Problems

      2005 - 2012

      Selected Presentations & Talks

      Regional Presentations

      1. 2022. Association Between Quitting Smoking and Survival in Cancer Patients. Conference. Society for Research on Nicotine and Tobacco. Baltimore, MD, US.

      National Presentations

      1. 2022. Association Between Quitting Smoking and Survival in Cancer Patients. Conference. Poster Presentation. Baltimore, MD, US.
      2. 2019. The effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Cessation among smokers with current and past major depression. Conference. SRNT. San Francisco, US.
      3. 2014. Addressing Heterogeneity in Syndemic Effects on Smoking Abstinence in Persons Living with HIV/AIDS. Conference. Society of Behavioral Medicine. Philadelphia, PA, US.
      4. 2013. Neighborhood risk and protective factors shaping child and adolescent behavior among Latino and African American youth. Conference. Case Western Reserve University. Cleveland, OH, US.
      5. 2013. Neighborhood Environments and Childhood Obesity. Conference. Case Western Reserve University. Cleveland, OH, US.
      6. 2012. Neighborhood risk and protective factors shaping child and adolescent behavior. Conference. Society for Social Work and Research. San Diego, CA, US.
      7. 2012. Estimating the effects of neighborhood on the physical health outcomes of Latino and African American youth. Conference. Association of Collegiate Schools of Planning. Cincinnati, OH, US.
      8. 2012. Estimating the effects of neighborhood on the physical health outcomes of Latino and African American youth. Conference. Association for Public Policy Analysis and Management. Baltimore, MD, US.
      9. 2012. The Relationship Between Quality of Life and Death for Advanced Stage Cancer Patients. Conference. Gerontological Society of America. San Diego, CA, US.
      10. 2012. Neighborhood effects on the educational outcomes of African American children. Conference. Society for the Study of Social Problems. Denver, CO, US.
      11. 2012. Well Being Trajectories among Patients Diagnosed with Advanced Stage. Conference. American Sociological Association. Denver, CO, US.
      12. 2012. Neighborhood Effects on the Educational Outcomes of African American Children. Conference. Society for the Study of Social Problems. Denver, CO, US.
      13. 2012. A Year in the Lives: Trajectories of Well-Being among Patients Diagnosed with Advanced Stage Cancer. Invited. Case Comprehensive Cancer Center, Case Western Reserve University. Cleveland, OH, US.
      14. 2012. Neighborhood risk and protective factors influencing the birth outcomes of low-income Latino and African American infants. Conference. Urban Affairs Association. Pittsburgh, PA, US.
      15. 2011. Dealing with Model Uncertainty by Model Averaging. Conference. Health Services Research Seminars. Center for Health Care Research. Cleveland, OH, US.
      16. 2010. A Comparison of MA and YOs Depressive Mood Trajectories with Antecedents care and quality of life over time. Conference. Gerontological Society of America Annual Meeting. New Orleans, LA, US.
      17. 2010. The Effects of Patients Trajectory of Psychosocial Well-Being on the Caregivers. Conference. American Sociological Association. Atlanta, GA, US.
      18. 2010. Issues in Longitudinal Analysis. Conference. Case Comprehensive Cancer Center. Cleveland, OH, US.
      19. 2009. Overview of Latent Variables and Mixtures. Conference. Metro Health Medical Center. Cleveland, OH, US.
      20. 2009. Patterns of Adaptation in Middle-Aged and Older Long-Term Survivors with Advanced Cancer. Conference. Case Comprehensive Cancer Center. Cleveland, OH, US.
      21. 2009. Psycho-Spiritual Heterogeneity in Long-Term Survivorship with Late-Stage Cancer. Conference. VA Medical Center. Cleveland, OH, US.

      International Presentations

      1. 2012. Estimating the effects of neighborhood on the health outcomes of Latino and African American youth. Conference. European Network for Housing Research. Lillehammer, NO.
      2. 2011. Identifying predictors of cancer related quality of life using Bayesian model averaging (BMA). Conference. International Conference on Health Policy Statistics. Cleveland, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2027 - 2032
      Title:Personalized Mobile Health for ADRD Caregivers: Biobehavioral Interpretable Machine Learning and Optimizing Delivery
      Funding Source:Rice University
      Role:Co-I
      ID:FP00027999_Res1
      Date: 2027 - 2032
      Title:Personalized Mobile Health for ADRD Caregivers: Biobehavioral Interpretable Machine Learning and Optimizing Delivery
      Funding Source:Rice University, NIH
      Role:Co-PI
      ID:FP00027999_Res1
      Date: 2027 - 2032
      Title:Reducing Cancer Recurrence Risk Through Combination Therapy in Survivors Motivated to Quit Smoking: a Randomized Clinical Trial
      Funding Source:National Institutes of Health
      Role:Co-I
      ID:1R01CA315928-01A1
      Date: 2027 - 2032
      Title:Psilocybin-Assisted Therapy for Refractory Tobacco Use in Cancer: Modulating Emotion-Cognition Neural Circuits to Promote Abstinence
      Funding Source:National Institutes of Health
      Role:Co-I
      ID:1R01CA313770-01A1
      Date: 2027 - 2031
      Title:Grief as Bioenergetic Work: Mitochondrial Capacity and Adaptation to Spousal Loss in Older Adults
      Funding Source:Rice University/ NIH
      Role:Co-I
      ID:FP00030709
      Date: 2027 - 2027
      Title:Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optimize Smoking Cessation
      Funding Source:National Insitiutes of Health
      Role:Co-I
      ID:3R01CA278938-03
      Date: 2026 - 2031
      Title:Personalized mobile health intervention for ADRD family caregivers: a biobehavioral interpretable machine learning approach
      Funding Source:Rice University
      Role:Co-PI
      ID:FP00026739_Res1
      Date: 2026 - 2030
      Title:Personalized Brain Stimulation to Combat Obesity and Reduce Cancer Risk
      Funding Source:Cancer Prevention and Research Institute of Texas
      Role:Co-PI
      ID:RP270471
      Date: 2026 - 2030
      Title:Reducing risk for cancer survivors who have excessive alcohol use and weight with glucagon-like peptide-1 receptor agonist treatment
      Funding Source:Cancer Prevention and Research Institute of Texas
      Role:Co-I
      ID:RP270011
      Date: 2026 - 2028
      Title:Effects of Extreme Heat Events on Lung Cancer Mortality in the US
      Funding Source:Lung Cancer Research Foundation
      Role:PI
      ID:FP00030715
      Date: 2026 - 2029
      Title:Personalized Neuromodulation for Obesity: A Bayesian Approach
      Funding Source:Cancer Prevention and Research Institute of Texas
      Role:PI
      ID:1R01DK14869-01A1
      Date: 2026 - 2031
      Title:Personalized Mobile Health for ADRD Caregivers: Biobehavioral Interpretable Machine Learning and Optimizing Delivery
      Funding Source:Rice University
      Role:Co-PI
      ID:FP00027999
      Date: 2026 - 2031
      Title:Cancer Prevention Research Training at MD Anderson Cancer Center
      Funding Source:National Institutes of Health
      Role:Mentor
      ID:1T32CA306834-01A1
      Date: 2026 - 2031
      Title:Reducing Cancer Recurrence Risk Through Combination Therapy in Survivors Motivated to Quit Smoking: a Randomized Clinical Trial
      Funding Source:National Institutes of Health
      Role:Co-I
      ID:# GRANT14504932
      Date: 2026 - 2028
      Title:ADRD spousal caregivers, loneliness, & immune dysregulation: Real-Time, real-world intervention targets
      Funding Source:Rice University
      Role:Co-I
      ID:FP00030953
      Date: 2026 - 2029
      Title:Personalized Neuromodulation for Obesity: A Bayesian Approach
      Funding Source:National Institutes of Health
      Role:PI
      ID:1R01DK146869-01
      Date: 2026 - 2028
      Title:Feasibility of a Multi-Modal Digital Smoking Reduction Intervention to Promote Cessation for Cancer Patients
      Funding Source:National Institutes of Health
      Role:Co-I
      ID:FP00026602
      Date: 2025 - 2030
      Title:Project CHROMA: A Randomized Trial of a Scalable Music Creativity Intervention for Mild Cognitive Impairment—Neural Moderators and Cellular Mechanisms
      Funding Source:Rice University
      Role:PI
      ID:1R01AG098667
      Date: 2025 - 2028
      Title:Personalized Brain Stimulation to Combat Obesity and Reduce Cancer Risk
      Funding Source:Cancer Prevention & Research Institute of Texas
      Role:Co-I
      ID:RP260065
      Date: 2025 - 2030
      Title:Predicting Weight Recurrence After Bariatric Surgery: Neurobehavioral Profiles as Early Indicators of Risk
      Funding Source:NATIONAL INSTITUTES OF HEALTH
      Role:PI
      ID:1R01DK145478-01
      Date: 2025 - 2030
      Title:Personalized mobile health intervention for ADRD family caregivers: a biobehavioral interpretable machine learning approach
      Funding Source:William Marsh Rice University
      Role:PI
      ID:1R01AG092007
      Date: 2025 - 2028
      Title:Decoding health risk factors for non-Communicable Diseases (NCDs): Life trends and services innovation
      Funding Source:Norwegian University of Science and Technology, NTNU
      Role:Consult
      Date: 2025 - 2031
      Title:Project CHROMA: A Randomized Trial of a Scalable Music Creativity Intervention for Mild Cognitive Impairment—Neural Moderators and Cellular Mechanisms
      Funding Source:Rice University
      Role:Co-I
      ID:FP00025354_Res1
      Date: 2025 - 2029
      Title:Advancing Cervical Cancer Screening Through Emergency Department-based HPV Self-Sampling
      Funding Source:University of Rochester
      Role:PI
      ID:FP00022802
      Date: 2025 - 2028
      Title:Personalized rTMS as an adjuvant to behavioral weight loss treatments: A proof-of-concept trial
      Funding Source:National Institutes of Health
      Role:Co-I
      ID:FP00023949
      Date: 2025 - 2030
      Title:Patient-Reported Outcome Measures as Decision Tools for Improving Patient-Centered Care in Chronic Cancer Pain
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      ID:1K08CA300880-01
      Date: 2025 - 2028
      Title:Characterizing Symptom Trajectories, Predictors of Symptoms, and Relevant Outcomes Among Survivors of Breast Cancer Receiving Endocrine Therapy
      Funding Source:American Cancer Society (ACS)
      Role:Co-I
      ID:1308308
      Date: 2025 - 2026
      Title:NTNU Cancer Prevention CARE: A Collaborative Alliance for Research and Education in Cancer Prevention
      Funding Source:Norwegian University of Science and Technology, NTNU
      Role:Consult
      Date: 2024 - 2029
      Title:Personalized mobile health intervention for ADRD family caregivers: a biobehavioral interpretable machine learning approach
      Funding Source:William Marsh Rice University, NIH
      Role:Co-I
      ID:R01AG092007
      Date: 2024 - 2027
      Title:Bayesian neurobehavioral phenotyping: from mechanism identification to personalized neuromodulation treatments
      Funding Source:National Institutes of Health/National Institute of Drug Abuse
      Role:Co-PI
      ID:1R61DA058276-01A1
      Date: 2024 - 2025
      Title:Personalized neurostimulation for smoking cessation in cancer patients: an image-guided approach
      Funding Source:MD Anderson Cancer Neuroscience Program
      Role:PI
      Date: 2024 - 2029
      Title:Supporting Tobacco-Related Education and Research (STRONGER) Scholar Program
      Funding Source:NIH/NIDA
      Role:Mentor
      ID:1 R25DA059907-01
      Date: 2024 - 2029
      Title:Persistent fatigue after curative treatment for breast cancer: is it a lack of energy?
      Funding Source:NIH/NCI
      Role:Collaborator
      ID:1 R01CA282256-01A1
      Date: 2024 - 2026
      Title:Houston Nutrition Obesity Research Center (H-NORC)- PILOT PROJECT: “Evaluating the Feasibility of Accelerated Theta Burst Stimulation as an Adjunct Therapy for Obesity: A Phase 1 Trial”
      Funding Source:Baylor College of Medicine
      Role:Co-I
      ID:P700001066
      Date: 2024 - 2025
      Title:Houston Nutrition Obesity Research Center (H-NORC) PILOT PROJECT: “Evaluating the Feasibility of Accelerated Theta Burst Stimulation as an Adjunct Therapy for Obesity: A Phase 1 Trial
      Funding Source:Baylor College of Medicine
      Role:Co-I
      ID:N/A
      Date: 2024 - 2028
      Title:Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optimal Smoking Cessation
      Funding Source:National Institutes of Health/ National Cancer Institute
      Role:Co-I
      ID:1R01CA278938-01A1
      Date: 2023 - 2028
      Title:Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optomized Smoking Cessation
      Funding Source:NIH/NCI
      Role:Co-I
      ID:1R01CA278938-01A1
      Date: 2023 - 2026
      Title:ADRD spousal caregivers, loneliness, & immune dysregulation: Real-Time, real-world intervention targets
      Funding Source:William Marsh Rice University, NIH
      Role:Principal Investigator-MDACC
      ID:1RF1AG075946-01A1
      Date: 2023 - 2028
      Title:Bayesian neurobehavioral phenotyping: from mechanism identification to personalized neuromodulation treatments
      Funding Source:NIH/NIDA
      Role:PI
      ID:1R61DA058276-01A1
      Date: 2023 - 2028
      Title:Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optimize Smoking Cessation
      Funding Source:NIH/NCI
      Role:Co-I
      ID:R01CA278938-01
      Date: 2023 - 2026
      Title:The impact of neighborhoods on smoking outcomes
      Funding Source:NIH/NCI
      Role:PI
      ID:1-R01-CA258353-01
      Date: 2022 - 2029
      Title:Comparative Effectiveness of Virtually Delivered Sequential Smoking Cessation Treatment
      Funding Source:PCORI
      Role:Co-I
      ID:25026
      Date: 2022 - 2025
      Title:A precision medicine approach to reducing overeating: neurocircuitry-informed transcranial magnetic stimulation
      Funding Source:NIH/NIDDK
      Role:Co-I
      ID:1 R01 DK133481-01
      Date: 2022 - 2024
      Title:Smartphone-delivered scheduled smoking with biochemical monitoring as an adjunct cessation therapy
      Funding Source:NIH/NCI
      Role:Co-I
      ID:1R21DA055765-01
      Date: 2021 - 2028
      Title:Comparative Effectiveness of Virtually Delivered Sequential Smoking Cessation Treatment
      Funding Source:PCORI
      Role:Co-I
      ID:21272
      Date: 2021 - 2023
      Title:Neighborhoods as Engine of Disparities in Smoking Outcomes
      Funding Source:Cancer Prevention Foundation
      Role:PI
      ID:MDACC
      Date: 2020 - 2026
      Title:The Potential Risks and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
      Funding Source:National Institutes of Health/ National Cancer Institute
      Role:Co-I
      ID:R01CA238478-A1
      Date: 2020 - 2025
      Title:Individual Differences in Dementia Spousal Caregiver Burden: A Biobehavioral Approach
      Funding Source:NIH/NCI
      Role:PI
      ID:3R01AG062690-02S1
      Date: 2020 - 2025
      Title:Individual Differences in Dementia Spousal Caregiver Burden: A Biobehavioral Approach
      Funding Source:William Marsh Rice University, NIH
      Role:Principal Investigator-MDACC
      ID:3 R01AG062690-02S1
      Date: 2020 - 2022
      Title:Individual differences in dementia spousal caregiver burden: A biobehavioral approach revision
      Funding Source:NIH/NCI
      Role:Co-I
      ID:R01AG062690
      Date: 2020 - 2022
      Title:Magnitudes and Mechanisms of Neighborhood Effects on Smoking Outcomes in the Greater Houston
      Funding Source:MDACC IRG
      Role:PI
      ID:MDACC
      Date: 2020 - 2022
      Title:Toward a precision medicine approach to reduce cue-induced overeating: neurocircuitry-informed transcranial magnetic stimulation
      Funding Source:NIH/NCI
      Role:Co-I
      ID:1R21DK124715-01
      Date: 2020 - 2025
      Title:Predicting vulnerability to prescription opioid abuse using neuropsychological endophenotypes
      Funding Source:NIH/NCI
      Role:Co-PI
      ID:1R01DA048793-01A1
      Date: 2020 - 2022
      Title:Assessment of the Potential Risks and Benefits of Electronic Cigarettes to Smokers at High Risk for Lung Cancer
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      ID:RP200305
      Date: 2020 - 2024
      Title:Health Behavior among Black and Non-Hispanic white Survivor-Caregiver Dyads
      Funding Source:American Cancer Society (ACS)
      Role:Co-I
      ID:MDACC
      Date: 2019 - 2023
      Title:Genetic substrates of a novel neural biomarker for smoking cessation
      Funding Source:American Association for Cancer Research (AACR)
      Role:Co-I
      ID:19-90-52-CINC
      Date: 2019 - 2023
      Title:Genetic substrates of a novel neural biomarker for smoking cessation
      Funding Source:American Association for Cancer Research (AACR)
      Role:Co-I
      ID:19-90-52-CINC
      Date: 2019 - 2024
      Title:Dementia spousal caregiver burden in the real world: Harnessing the power of the health sensor revolution to identify mental and physical health risks
      Funding Source:William Marsh Rice University
      Role:Consult
      ID:R01AG065724
      Date: 2019 - 2022
      Title:Improving the Quality of Smoking Cessation and Shared Decision Making for Lung Cancer Screening: A Cluster Randomized Trial
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      ID:RP190210
      Date: 2018 - 2023
      Title:Gender differences in Standard Research E-Cigarette (SREC) product use, acceptability, reinforcement, and nicotine dependence symptoms
      Funding Source:NIH/NIDA
      Role:Co-I
      ID:U01DA047875
      Date: 2017 - 2020
      Title:Behavioral mechanisms, prediction, and treatment of short-term suicide risk
      Funding Source:American Foundation of Suicide Prevention
      Role:Consult
      ID:STR-0-004-16
      Date: 2017 - 2020
      Title:Glutamate receptor and kynurenine pathway functioning in the pathobiology of Gulf War Illness
      Funding Source:Department of Defense (DOD)
      Role:Consult
      ID:GW1600077
      Date: 2016 - 2022
      Title:Optimizing Effectiveness of Smoking Cessation Invention During LDCT screening for Lung Cancer
      Funding Source:NIH/NCI
      Role:Co-I
      ID:R01CA207078-01
      Date: 2016 - 2022
      Title:Evaluating Concomitant Use of Very Low Nicotine Content Cigarettes and E-Cigarettes Among Daily and Non-Daily Smokers on Abuse Liability
      Funding Source:NIH/FDA
      Role:Co-I
      ID:R01 DA042526-01
      Date: 2015 - 2018
      Title:The potential risks and benefits of electronic cigarettes to smokers with chronic obstructive pulmonary disease (COPD)
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2013 - 2016
      Title:Using Deep Sequencing Technology to Study Genes & Behavioral Phenotypes Related to Smoking Cessation, Negative affect & Nicotine Withdrawal
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      ID:RP130123
      Date: 2013 - 2017
      Title:Neighborhood factors and child maltreatment: A mixed method study
      Funding Source:NIH/NCRR
      Role:Co-I
      ID:5-R01HD077002-02
      Date: 2013 - 2015
      Title:Leveraging Integrated Data Systems (IDS) to examine the Role of Housing and Neighborhood Conditions on School Readiness and Early Literacy
      Funding Source:John T. and Catherine C. MacArthur Foundation
      Role:Co-I

      Selected Publications

      Peer-Reviewed Articles

      1. Minnix, JA, Kypriotakis, G, Blalock, J, Green, CE, Karam-Hage, M, Robinson, JD, Cinciripini, PM. Characterization of Cognitive-Behavioral Counseling Duration Thresholds for Effective Tobacco Treatment. Nicotine and Tobacco Research 28(4):569-576, 2026. e-Pub 2026. PMID: 40847822.
      2. Robinson, JD, Anthenelli, RM, Cinciripini, PM, Karam-Hage, M, Cui, Y, Kypriotakis, G, Ait-Daoud Tiouririne, N. High- and low-dose topiramate for the treatment of persons with alcohol use disorder who smoke cigarettes. Alcohol, Clinical and Experimental Research 49(12):2865-2874, 2025. e-Pub 2025. PMID: 41220371.
      3. Beneventi, DM, Kypriotakis, G, Kotsen, C, Karam-Hage, M, Robinson, JD, Minnix, JA, Cinciripini, PM. Real-world comparison of phone versus video consultation in a tobacco treatment program during the COVID-19 pandemic. Patient Education and Counseling 141, 2025. e-Pub 2025. PMID: 40945190.
      4. Murphy, NR, Kypriotakis, G, Lijffijt, M, Iqbal, S, Iqbal, T, Amarneh, D, O'Brien, B, Tamman, A, Thomas, YT, Moukaddam, N, Kosten, TR, Averill, LA, Mathew, SJ, Swann, AC. Interacting immediate and long-term action regulation in suicidal behavior. Journal of Mood and Anxiety Disorders 10, 2025. e-Pub 2025. PMID: 40657602.
      5. Cinciripini, PM, Minnix, JA, Kypriotakis, G, Erasmus, JJ, Beneventi, DM, Karam-Hage, M, Carpenter, K, Volk, R, Carter, B, Godoy, M, Strange, CD, Shih, YT, Cui, Y, Green, CE, Robinson, JD. Smoking Cessation Interventions in the Lung Cancer Screening Setting. JAMA Internal Medicine 185(3):284-291, 2025. e-Pub 2025. PMID: 39804633.
      6. Robinson, JD, Cui, Y, Karam-Hage, M, Blalock, J, Shete, S, Kypriotakis, G, Yang, P, Cinciripini, PM. Standardized research electronic cigarette acceptability among adult men and women who smoke combustible cigarettes. Psychology of Addictive Behaviors 39(8):780-791, 2025. e-Pub 2025. PMID: 41051837.
      7. Cinciripini, PM, Kypriotakis, G, Blalock, JA, Karam-Hage, M, Beneventi, DM, Robinson, JD, Minnix, JA, Warren, GW. Survival Outcomes of an Early Intervention Smoking Cessation Treatment after a Cancer Diagnosis. JAMA Oncology 10(12):1689-1696, 2024. e-Pub 2024. PMID: 39480450.
      8. Cinciripini, PM, Wetter, DW, Wang, J, Yu, R, Kypriotakis, G, Kumar, T, Robinson, JD, Cui, Y, Green, CE, Bergen, AW, Kosten, TR, Scherer, S, Shete, S. Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample. Scientific reports 14(1), 2024. e-Pub 2024. PMID: 38493193.
      9. Robinson, JD, Cui, Y, Kypriotakis, G, Engelmann, JM, Karam-Hage, M, Minnix, JA, Green, CE, Shete, S, Hatsukami, D, Donny, EC, Murphy, SE, Hecht, SS, Eissenberg, T, Wetter, DW, Cinciripini, PM. Evaluating the Human Abuse Potential of Concurrent Use of Electronic Cigarettes and Low Nicotine Cigarettes Among Adults Who Smoke. Experimental and clinical psychopharmacology 33(2):133-144, 2024. e-Pub 2024. PMID: 39541521.
      10. Rodríguez-Cano R, Kypriotakis G, Robinson JD, Karam-Hage M, Blalock JA, Minnix JA, Beneventi D, Cinciripini PM. Comparing the Fagerström Test and Heaviness of Smoking Index in Predicting Smoking Abstinence in Cancer Patients. Nicotine Tob Res 26(11):1576-1581, 2024. e-Pub 2024. PMID: 38785358.
      11. Murphy, NR, Pham, G, Weyland, A, Engelhardt, J, Kypriotakis, G, Thomas, YT, Kosten, TR, Moukaddam, N, Mathew, SJ, Swann, AC. Lithium reduces impulsive decision making in transdiagnostic patients at high risk for suicide attempt recurrence. Neurology Psychiatry and Brain Research 17, 2024. e-Pub 2024.
      12. Robinson, J D, Cui, Y, Engelmann, J M, Kypriotakis, G, Cinciripini, P M. Using eye tracking to evaluate the impact of smartphone-delivered attentional bias modification training for smokers. Experimental & Clinical Psychopharmacology 32(6):728-736, 2024. e-Pub 2024. PMID: 38934914.
      13. Robinson JD, Kypriotakis G, Karam-Hage M, Cui Y, Beneventi D, Blalock JA, Minnix JA, Cinciripini PM. Brief Report: Characterization of electronic cigarette use among patients of a comprehensive cancer center. Am J Addict 33(3):339-342, 2024. e-Pub 2023. PMID: 37807121.
      14. Kypriotakis G, Kim S, Karam-Hage M, Robinson JD, Minnix JA, Blalock JA, Cui Y, Beneventi D, Kim B, Pan IW, Shih YT, Cinciripini PM. Examining the Association between Abstinence from Smoking and Healthcare Costs Among Patients with Cancer. Cancer Prev Res (Phila) 17(5):217-225, 2024. e-Pub 2024. PMID: 37940143.
      15. Cinciripini PM, Green CE, Shete S, Minnix JA, Robinson JD, Cui Y, Kim S, Kypriotakis G, Beneventi D, Blalock JA, Versace F, Karam-Hage M. Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial. JAMA 331(20):1722-1731, 2024. e-Pub 2024. PMID: 38696203.
      16. Cinciripini PM, Kypriotakis G, Shete S. Deep sequencing genetic study identified 14 variants associated with smoking abstinence in an ethnically diverse sample. Scientific Reports. e-Pub 2024. PMID: 38493193.
      17. Markodimitraki, M, Charitaki, G, Kypriotaki, M, Fragogianni, ME, Kypriotakis, G. The role of marital satisfaction and social activities on parents’ self-perception. International Journal of Developmental Disabilities 70(3):444-457, 2024. e-Pub 2024. PMID: 38699496.
      18. Cui Y, Robinson JD, Kypriotakis G, Minnix JA, Green CE, Kim S, Karam-Hage M, Cinciripini PM. Comparable cigarette consumption data collected using timeline follow-back and digital diary among treatment-seeking smokers. Psychology of Addictive Behaviors 38(3):315-322, 2023. e-Pub 2023. PMID: 37747518.
      19. Gibney, KD, Kypriotakis, G, Versace, F. Individual differences in late positive potential amplitude and theta power predict cue-induced eating. Addiction Neuroscience 7, 2023. e-Pub 2023. PMID: 37711965.
      20. Cinciripini PM, Minnix JA, Robinson JD, Kypriotakis G, Cui Y, Blalock JA, Lam CY, Wetter DW. The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation: Randomized Controlled Trial With Compliance. JMIR Form Res 7:e39487, 2023. e-Pub 2023. PMID: 37338956.
      21. Versace F, Kypriotakis G, Pluta D. Neuroaffective reactivity profiles are associated with vulnerability to e-cigarette use. Drug Alcohol Depend 247:109871, 2023. e-Pub 2023. PMID: 37084510.
      22. Rodriguez-Cano, R, Kypriotakis, G, Cortés-García, L, Bakken, A, von Soest, T. Polysubstance use and its correlation with psychosocial and health risk behaviours among more than 95,000 Norwegian adolescents during the COVID-19 pandemic (January to May 2021). The Lancet Regional Health - Europe 28, 2023. e-Pub 2023. PMID: 37131865.
      23. Lowenstein LM, Shih YT, Minnix J, Lopez-Olivo MA, Maki KG, Kypriotakis G, Leal VB, Shete SS, Fox J, Nishi SP, Cinciripini PM, Volk RJ. A protocol for a cluster randomized trial of care delivery models to improve the quality of smoking cessation and shared decision making for lung cancer screening. Contemp Clin Trials 128:107141, 2023. e-Pub 2023. PMID: 36878389.
      24. Cinciripini PM, Kypriotakis G, Green C, Lawrence D, Anthenelli RM, Minnix J, Blalock JA, Beneventi D, Morris C, Karam-Hage M. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial. Depress Anxiety 39(5):429-440, 2022. e-Pub 2022. PMID: 35535436.
      25. Robinson JD, Karam-Hage M, Kypriotakis G, Beneventi D, Blalock JA, Cui Y, Gonzalez R, Tayar J, Chaftari P, Cinciripini PM. Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict 31(3):236-241, 2022. e-Pub 2022. PMID: 35347796.
      26. Gibney KD, Kypriotakis G, Versace F. Individual differences in late positive potential amplitude and theta power predict cue-induced eating. bioRxiv, 2022. e-Pub 2022.
      27. Singareeka Raghavendra A, Kypriotakis G, Karam-Hage M, Kim S, Jizzini M, Seoudy KS, Robinson JD, Barcenas CH, Cinciripini PM, Tripathy D, Ibrahim NK. The Impact of Treatment for Smoking on Breast Cancer Patients' Survival. Cancers (Basel) 14(6), 2022. e-Pub 2022. PMID: 35326615.
      28. Robinson JD, Cui Y, Karam-Hage M, Kypriotakis G, Versace F, Ait-Daoud Tiouririne N, Anthenelli RM, Cinciripini PM. Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder. Alcohol Clin Exp Res 46(3):384-395, 2022. e-Pub 2022. PMID: 35037278.
      29. Deweese MM, Versace F, Kypriotakis G, Dirba D, Daniel CR, Schembre SM. Satiety does not affect neuroaffective electrophysiological responses to food-related or emotional visual cues. Behav Neurosci 135(4):571-580, 2021. e-Pub 2021. PMID: 33844564.
      30. Kypriotakis G, Cinciripini PM, Versace F. Modeling Neuroaffective Biomarkers of Drug Addiction: A Bayesian Nonparametric Approach using Dirichlet Process Mixtures. J Neurosci Methods 341:108753, 2020. e-Pub 2020. PMID: 32428623.
      31. Frank DW, Cinciripini PM, Deweese MM, Karam-Hage M, Kypriotakis G, Lerman C, Robinson JD, Tyndale RF, Vidrine DJ, Versace F. Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse. Nicotine Tob Res 22(8):1277-1284, 2020. e-Pub 2020. PMID: 31724052.
      32. Robinson JD, Kypriotakis G, Al'absi M, Denlinger-Apte RL, Drobes DJ, Leischow SJ, McClernon FJ, Pacek LR, Severson HH, Smith TT, Donny EC, Luo X, Jensen JA, Strayer LG, Cinciripini PM, Hatsukami DK. Very low nicotine content cigarettes disrupt the feedback loop of affective states and smoking behavior. Nicotine Tob Res 22(8):1294-1300, 2020. e-Pub 2020. PMID: 31701153.
      33. Gibney KD, Kypriotakis G, Cinciripini PM, Robinson JD, Minnix JA, Versace F. Estimating statistical power for event-related potential studies using the late positive potential. Psychophysiology 57(2):e13482, 2020. e-Pub 2020. PMID: 31608456.
      34. Cinciripini PM, Karam-Hage M, Kypriotakis G, Robinson JD, Rabius V, Beneventi D, Minnix JA, Blalock JA. Association of a Comprehensive Smoking Cessation Program With Smoking Abstinence Among Patients With Cancer. JAMA Netw Open 2(9):e1912251, 2019. e-Pub 2019. PMID: 31560387.
      35. Stevens EM, Frank D, Codispoti M, Kypriotakis G, Cinciripini PM, Claiborne K, Deweese MM, Engelmann JM, Green CE, Karam-Hage M, Minnix JA, Ng J, Robinson JD, Tyndale RF, Vidrine DJ, Versace F. The Late positive potentials evoked by Cigarette-Related and emotional Images show no Gender Differences in Smokers. Sci Rep 9(1):3240, 2019. e-Pub 2019. PMID: 30824792.
      36. Kypriotakis G, Robinson JD, Green CE, Cinciripini PM. Patterns of Tobacco Product Use and Correlates Among Adults in the Population Assessment of Tobacco and Health (PATH) Study: A Latent Class Analysis. Nicotine Tob Res 20(suppl_1):S81-S87, 2018. e-Pub 2018. PMID: 30125013.
      37. Karam-Hage M, Kypriotakis G, Robinson JD, Green CE, Mann G, Rabius V, Wippold R, Blalock JA, Mouhayar E, Tayar J, Chaftari P, Cinciripini PM. Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis. J Clin Psychopharmacol 38(1):34-41, 2018. e-Pub 2018. PMID: 29232312.
      38. Robinson JD, Kypriotakis G, Karam-Hage M, Green CE, Hatsukami DK, Cinciripini PM, Donny EC. Cigarette nicotine content as a moderator of the relationship between negative affect and smoking. Nicotine Tob Res 19(9):1080-1086, 2017. e-Pub 2017. PMID: 28371900.
      39. Francis LE, Kypriotakis G, O'Toole EE, Rose JH. Cancer patient age and family caregiver bereavement outcomes. Support Care Cancer 24(9):3987-96, 2016. e-Pub 2016. PMID: 27129838.
      40. Versace F, Kypriotakis G, Basen-Engquist K, Schembre SM. Heterogeneity in brain reactivity to pleasant and food cues: evidence of sign-tracking in humans. Soc Cogn Affect Neurosci 11(4):604-11, 2016. e-Pub 2016. PMID: 26609106.
      41. Kypriotakis G, Vidrine DJ, Francis LE, Rose JH. The longitudinal relationship between quality of life and survival in advanced stage cancer. Psychooncology 25(2):225-31, 2016. e-Pub 2016. PMID: 25959260.
      42. Buchberg MK, Gritz ER, Kypriotakis G, Arduino RC, Vidrine DJ. The Role of BMI Change on Smoking Abstinence in a Sample of HIV-Infected Smokers. AIDS Care 28(5):603-7, 2016. e-Pub 2016. PMID: 26666313.
      43. Francis LE, Kypriotakis G, O’Toole E, Rose JH. Patient Age and Family Caregiver Bereavement Outcomes. Forthcoming in Supportive Care in Cancer, 2016. e-Pub 2016.
      44. Kypriotakis G, Deimling GT, Piccinin AM, Hofer SM. Correlated and Coupled Trajectories of Cancer-Related Worries and Depressive Symptoms among Long-Term Cancer Survivors. Behav Med 42(2):1-11, 2016. e-Pub 2016. PMID: 25085102.
      45. Vidrine DJ, Kypriotakis G, Li L, Arduino RC, Fletcher FE, Tamí-Maury I, Gritz ER. Mediators of a smoking cessation intervention for persons living with HIV/AIDS. Drug Alcohol Depend 147:76-80, 2015. e-Pub 2015. PMID: 25542824.
      46. Francis LE, Kypriotakis G, O'Toole EE, Bowman KF, Rose JH. Grief and risk of depression in context: the emotional outcomes of bereaved cancer caregivers. Omega (Westport) 70(4):351-79, 2015. e-Pub 2015. PMID: 26036059.
      47. Kohut RM, Minnillo BJ, Kypriotakis G, Abouassaly R, Zhu H. Changes in adjuvant therapy utilization in stage I seminoma: are they enough to prevent overtreatment?. Urology 84(6):1319-24, 2014. e-Pub 2014. PMID: 25432823.
      48. Kypriotakis G, Francis LE, O'Toole E, Towe TP, Rose JH. Preferences for aggressive care in underserved populations with advanced-stage lung cancer: looking beyond race and resuscitation. Support Care Cancer 22(5):1251-9, 2014. e-Pub 2014. PMID: 24317850.
      49. Step MM, Kypriotakis G, Rose JH. An Exploration of the relative influence of patient's age and cancer recurrence status on symptom distress, anxiety, and depression over time. J Psychosoc Oncol 31(2):168-90, 2013. e-Pub 2013. PMID: 23514253.
      50. Jump RL, Olds DM, Seifi N, Kypriotakis G, Jury LA, Peron EP, Hirsch AA, Drawz PE, Watts B, Bonomo RA, Donskey CJ. Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use. Infect Control Hosp Epidemiol 33(12):1185-92, 2012. e-Pub 2012. PMID: 23143354.
      51. Slomka J, Kypriotakis G, Atkinson J, Diamond PM, Williams ML, Vidrine DJ, Andrade R, Arduino R. Factors associated with past research participation among low-income persons living with HIV. AIDS Patient Care STDS 26(8):496-505, 2012. e-Pub 2012. PMID: 22686261.
      52. Francis LE, Bowman KF, Kypriotakis G, Rose JH. Relationships and emotional wellbeing among African American and White advanced cancer caregivers. Patient Educ Couns 85(3):446-53, 2011. e-Pub 2011. PMID: 21439755.
      53. Jump RL, Li Y, Pultz MJ, Kypriotakis G, Donskey CJ. Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production. Antimicrob Agents Chemother 55(2):546-9, 2011. e-Pub 2011. PMID: 21135181.
      54. Kresevic D, Burant C, Denton J, Heath B, Kypriotakis G. The use of multimodal strategies for distance education in the GRECCs. Gerontol Geriatr Educ 32(1):54-79, 2011. e-Pub 2011. PMID: 21347931.
      55. Francis LE, Worthington J, Kypriotakis G, Rose JH. Relationship quality and burden among caregivers for late-stage cancer patients. Support Care Cancer 18(11):1429-36, 2010. e-Pub 2010. PMID: 19898879.
      56. Bowman KF, Rose JH, Deimling GT, Kypriotakis G, O'Toole EE. Primary care physicians' involvement in the cancer care of older long-term survivors. J Aging Health 22(5):673-86, 2010. e-Pub 2010. PMID: 20595104.
      57. Deimling GT, Arendt JA, Kypriotakis G, Bowman KF. Functioning of older, long-term cancer survivors: the role of cancer and comorbidities. J Am Geriatr Soc 57 Suppl 2:S289-92, 2009. e-Pub 2009. PMID: 20122020.
      58. Rose JH, Kypriotakis G, Bowman KF, Einstadter D, O'Toole EE, Mechekano R, Dawson NV. Patterns of adaptation in patients living long term with advanced cancer. Cancer 115(18 Suppl):4298-310, 2009. e-Pub 2009. PMID: 19731358.
      59. Kypriotakis G. Criminal histories and recidivism rates for different offense transitions and for two types of offenders. Discourse of Sociological Practice, 2001. e-Pub 2001.
      60. Rodríguez-Cano R, Kypriotakis G, Cortés-García L, Bakken A, Von Soest T. Polysubstance use and correlations with psychosocial and health risk behaviours: A latent profile analysis among more than 95,000 Norwegian adolescents during the COVID-19 pandemic. PsyArXiv:25.
      61. Kypriotakis G, Cinciripini PM, Green C, Lawrence D, Anthenelli RM, Minnix JA, Beneventi D, Morris C, Karam-Hage M, Blalock JA. The effects of varenicline, bupropion, nicotine patch and placebo on treating smoking among persons with current or past major depressive disorder: Secondary analysis of a double-blind, randomized, placebo-controlled trial. American Journal of Psychiatry.
      62. Cui Y, Robinson JD, Kim S, Kypriotakis G, Green CE, Shete SS, Cinciripini PM. An Open-Source Web App for Creating and Scoring Qualtrics-based Implicit Association Test. Behav Res Methods.
      63. Blalock JA, Kypriotakis G, Mathew AR, Robinson JD, Brown RA, Taylor AN, Karam-Hage M, McCullough J, Cinciripini PM. A Randomized Controlled Pilot Study with Frequentist and Bayesian Analysis of a Mood Management Smoking Cessation Intervention in Smokers with Current Chronic Depressive Disorders. Drug Alcohol Depend.
      64. Kypriotakis, G, Bernstein, SL, Bold, K, Dziura, JD, Hedeker, D, Mermelstein, RJ, Weinberger, AH. A practical guide to strategies for analyzing longitudinal data in clinical trials of tobacco use disorder treatment: Beyond dichotomous point-prevalence outcomes. Nicotine & Tobacco Research.
      65. Rodríguez-Cano, R, Kypriotakis, G, Robinson, JD, Karam-Hage, M, Blalock, JA, Minnix, JA, Beneventi, D, Cinciripini, P M. Comparing the Fagerström Test and Heaviness of Smoking Index in Predicting Smoking Abstinence in Cancer Patients. Nicotine and Tobacco Research.
      66. Robinson JD, Kypriotakis G, Karam-Hage M, Cui Y, Beneventi D, Blalock JA, Cinciripini PM. Characterization of Electronic cigarette use among patients of a comprehensive cancer center. JAMA.

      Invited Articles

      1. Rodriguez-Cano R, Kypriotakis G, Cortes-Garcia L, Bakken A, von soest T. Polysubstance use and its correlation with psychosocial and health risk behaviours among more than 95,000 Norwegian adolescents during the COVID-19 pandemic (January to May 2021): a latent profile analysis. The LANCET Regional Health Europe, 2023. e-Pub 2023.

      Review Articles

      1. Minnix, JA, Kypriotakis, G, Blalock, JA, Green CE, Karam-Hage M, Robinson JD, Cinciripini, PM. Characterization of Cognitive-Behavioral Counseling Duration Thresholds for Effective Tobacco Treatment. e-Pub 2025.
      2. Nicholas, M, Kypriotakis G, Marijin L, Iqbal S, Iqbal T, Amarneh D, O'Brien B. INTERACTING IMMEDIATE AND LONG-TERM ACTION REGULATION IN SUICIDAL BEHAVIOR. Journal of Mood & Anxiety Disorders, 2025. e-Pub 2025.
      3. Kypriotakis, G, Bernstein, SL, Bold, KW, Dziura, JD, Hedeker, D, Mermelstein, R, Weinberger, AH. An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment. Nicotine and Tobacco Research 26(7):796-805, 2024. e-Pub 2024. PMID: 38214037.

      Professional Educational Materials

      1. Mahmood A, Kypriotakis G, Karam-Hage M, Beneventi D, Minnix JA, Robinson JD, Cinciripini PM, Blalock JA. The Relationships of Childhood Trauma and Post-Traumatic Stress Disorder to Smoking Outcomes in Cancer Patients. SRNT 2023 Annual Meeting, 2023.

      Other Articles

      1. Kypriotakis, G Public interest technology for cancer survivorship in Texas. Cancer 132(4), 2026. PMID: 41686475.
      2. Cinciripini PM, Kypriotakis G, Minnix JA, Beneventi D, Karam-Hage M, Carpenter K, Volk RJ, Carter B, Goday M, Strange C, Shih Y-C, Cui Y, Green CE, Robinson JD Optimizing the Effectiveness of Tobacco Treatment in the Low-Dose CT Lung Cancer Screening Setting: A Randomized Clinical Trial. JAMA Intern Med, 2024.
      3. Robinson JD, Cui Y, Kypriotakis G, Englemann JM, Karam-Hage M, Minnix JA, Green CE, Shete S, Hatsukami DK, Donny EC, Murphy SE, Hecht SS, Eissenberg T, Wetter DW, Cinciripini PM Evaluating the abuse liability of concurrent use of electronic cigarettes and low nicotine cigarettes among adults who smoke. Experimental and Clinical Psychopharmacology.
      4. Jacobs, W, Jackson, A, Tan, AS, Martinez, SA, Addicott, M, Denlinger-Apte, R, Kypriotakis, G, Mithi, V, Patten, CA, Castro, Y Perceived Impact of Society for Research on Nicotine and Tobacco Health Equity Network's Pre-conference Workshops on Attendees' Professional Development. Nicotine and Tobacco Research 26(7):959-960, 2024. PMID: 38297962.
      5. Versace F, Kypriotakis G Neuroaffective profiles are associated with e-cigarette use. bioRxiv, 2022.
      6. Santiago AM, Galster GC, Lucero JL, Ishler KJ, Lee EL, Kypriotakis G, Stack L Opportunity neighborhoods for Latino and African American children. U.S. Department of Housing and Urban Development Washington, D.C, 2014.

      Abstracts

      1. Cinciripini PM, Kypriotakis G, Blalock J, Karam-Hage M, Beneventi D, Robinson JD, Minnix J, Warren G. The Effect Of Smoking Cessation Following A Cancer Diagnosis On Survival. SRNT - Edinburgh, Scotland. e-Pub 2024.
      2. Robinson JD, Cui Y, Kypriotakis G, Engelmann JM, Minnix JA, Green CE, Shete S, Hatsukami DK, Donny EC, Murphy SE, Hecht SS, Eissenberg TE, Wetter DE, Cinciripini PM. Dual use of electronic cigarettes and very low nicotine content combustible cigarettes during a product exposure clinical trial. SRNT - Edinburgh, Scotland, 2024. e-Pub 2024.
      3. Minnix JA, Kypriotakis G, Erasmus J, Beneventi D, Karam-Hage M, Carpenter K, Volk RJ, Carter B, Godoy M, Strange C, Shih T, Cui Y, Green CE, Robinson JD, Cinciripini PM. Project Luna: Optimizing The Effectiveness Of A Smoking Cessation Intervention In The Low-Dose Ct Lung Cancer Screening Setting. SRNT - Edinburgh, Scotland, 2024. e-Pub 2024.
      4. Rodríguez-Cano R, Kypriotakis G, Robinson JD, Karam‐Hage, M, Blalock, JA, Minnix JA, Beneventi D, D, Cinciripini PM. FTCD VS HSI Which Measure Of Dependence More Accurately Predicts Smoking Abstinence Among Cancer Patients Undergoing Smoking Cessation Treatment In A Comprehensive Cancer Center?. SRNT - Edinburgh, Scotland, 2024. e-Pub 2024.
      5. Robinson JD, Kypriotakis G, Karam-Hage M, Cui Y, Beneventi D, Blalock JA, Minnix JA, Cinciripini PM. Characterization of electronic cigarette use among patients of a comprehensive cancer center. e-Pub 2023. PMID: 37807121.
      6. Mahmood A, Blalock J, Kypriotakis G, Karam-Hage M. The Relationships of Childhood Trauma and Post Traumatic Stress Disorder to Smoking Outcomes in Cancer Patients, 2022. e-Pub 2022.
      7. Simmons T, Blalock J, Cinciripini P, Beneventi D, Minnix J, Karam-Hage M, Robinson J, Kypriotakis G. Association Between Quitting Smoking and Survival in Cancer Patients. SRNT Poster, 2022. e-Pub 2022.
      8. Nitturi V, Kypriotakis G, Beneventi D, Minnix J, Blalock J, Robinson J, Gonzalez R, Cinciripini P, Karam-Hage M. Impact of Treating Insomnia Symptoms on Abstinence from Smoking. SRNT Poster, 2022. e-Pub 2022.
      9. Kypriotakis G. Advance Longitudinal Models of Abstinence and Withdrawal. SRNT Poster, 2022. e-Pub 2022.
      10. Simmons TA, Kypriotakis G, Blalock J. Association Between Quitting Smoking and Survival in Cancer Patients. The University of Texas MD Anderson Cancer Center, 2021. e-Pub 2021.
      11. Nitturi V, Kypriotakis G, Karam-Hage M. Impact of Treating Insomnia Symptoms on Abstinence from Smoking. The University of Texas MD Anderson Cancer Center, 2021. e-Pub 2021.
      12. Karam-Hage M, Seoudy K, Kypriotakis G, Beneventi D, Minnix J, Robinson J, Blalock J, Cui Y, Cinciripini PM. The Effect of Baseline Insomnia and its Treatment on the Ability to Quit Smoking. AMERICAN JOURNAL ON ADDICTIONS 29(3):222-222, 2020. e-Pub 2020.
      13. Seoudy K, Kypriotakis G, Beneventi D, Blalock JA, Minnix JA, Robinson JD, Cinciripini PM, Karam-Hage M. The impact of major depressive disorder and depressive symptoms on the ability to quit smoking: A Case Control Cohort. Journal of Affective Disorders, 2019. e-Pub 2019.
      14. Seoudy K, Kypriotakis G, Beneventi D, Blalock B, Minnix J, Robinson J, Cui Y, Karam-Hage M. Real-Time Audio/Video Versus In-Person Treatment for Smoking. American Journal of Addictions, 2019. e-Pub 2019.
      15. Jizzini M, Raghavendra AS, Ibrahim NK, Kypriotakis G, Cinciripini PM, Seoudy K, Karam-Hage MA. The impact of smoking cessation on breast cancer patients’ survival. Journal of Clinical Oncology, 2019. e-Pub 2019.
      16. Kypriotakis G, Lawrence D, Green C, Anthenelli R, Morris C, Samuels L, Cinciripini P. The effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Cessation among smokers with current and past major depression, 2019. e-Pub 2019.
      17. Kypriotakis G, Vidrine D. The Role of identity-related motivation to quit and smoking attitudes in persons living with HIV. Annals of Behavioral Medicine, 2015. e-Pub 2015.
      18. Kypriotakis G. Addressing Heterogeneity in Syndemic Effects on Smoking Abstinence in Persons Living with HIV/AIDS. Society of Behavioral Medicine, 2014. e-Pub 2014.
      19. Kypriotakis G. Neighborhood risk and protective factors shaping child and adolescent behavior among Latino and African American youth. Research ShowCASE, Case Western Reserve University, 2013. e-Pub 2013.
      20. Kypriotakis G. Neighborhood Environments and Childhood Obesity. 2013 Research ShowCASE, Case Western Reserve University, 2013. e-Pub 2013.
      21. Kypriotakis G. Neighborhood risk and protective factors shaping child and adolescent behavior. Society for Social Work and Research, 2013. e-Pub 2013.
      22. Kypriotakis G. Estimating the effects of neighborhood on the physical health outcomes of Latino and African American youth. Association of Collegiate Schools of Planning, 2012. e-Pub 2012.
      23. Kypriotakis G. Estimating the effects of neighborhood on the physical health outcomes of Latino and African American youth. Association for Public Policy Analysis and Management, 2012. e-Pub 2012.
      24. Kypriotakis G. The Relationship Between Quality of Life and Death for Advanced Stage Cancer Patients. Gerontological Society of America, 2012. e-Pub 2012.
      25. Kypriotakis G. Well Being Trajectories among Patients Diagnosed with Advanced Stage Cancer. American Sociological Association, 2012. e-Pub 2012.
      26. Kypriotakis G. Neighborhood Effects on the Educational Outcomes of African American Children. Society for the Study of Social Problems, 2012. e-Pub 2012.
      27. Kypriotakis G. Estimating the effects of neighborhood on the health outcomes of Latino and African American youth. European Network for Housing Research, 2012. e-Pub 2012.
      28. Kypriotakis G. Neighborhood risk and protective factors influencing the birth outcomes of low-income Latino and African American infants. Urban Affairs Association, 2012. e-Pub 2012.
      29. Kypriotakis G. Psycho-Spiritual Heterogeneity in Long-Term Survivorship with Late-Stage Cancer. VA Medical Center, Cleveland, OH, 2012. e-Pub 2012.
      30. Kypriotakis G. Identifying predictors of cancer related quality of life using Bayesian model averaging (BMA). International Conference on Health Policy Statistics, 2011. e-Pub 2011.
      31. Kypriotakis G. Dealing with Model Uncertainty by Model Averaging. Health Services Research Seminars. Center for Health Care Research, 2011. e-Pub 2011.
      32. Kypriotakis G. A Comparison of MA and YOs Depressive Mood Trajectories with Antecedents care and quality of life over time. Gerontological Society of America, 2010. e-Pub 2010.
      33. Kypriotakis G. The Effects of Patients Trajectory of Psychosocial Well-Being on the Caregivers. American Sociological Association, 2010. e-Pub 2010.
      34. Kypriotakis G. Issues in Longitudinal Analysis. Case Comprehensive Cancer Center, Cleveland, OH, 2010. e-Pub 2010.
      35. Bowman KF, Rose JH, Deimling GT, Kypriotakis G, O'Toole EE. Primary care physicians’ involvement in the cancer care of older long-term survivors. Journal of Aging and Health 22(5):673-686, 2010. e-Pub 2010.
      36. Deimling GT, Arendt JA, Kypriotakis G, Bowman KF. Functioning of Older, Long-Term Cancer Survivors: The Role of Cancer and Comorbidities. Journal of the American Geriatrics Society 57(2):289-292, 2009. e-Pub 2009.

      Web Publications

      1. Jim Kling, Kypriotakis G. In metastatic NSCLC, better QoL outcomes tied to better outcomes, 2023.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 27, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top